News
CMMB
1.530
-7.27%
-0.120
Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)
TipRanks · 9h ago
Weekly Report: what happened at CMMB last week (0706-0710)?
Weekly Report · 1d ago
Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal
NASDAQ · 4d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
Chemomab to merge with Scipher Medicine
Seeking Alpha · 6d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 6d ago
Chemomab Therapeutics and Scipher Medicine to Merge in AI‑Driven Rheumatoid Arthritis Play
TipRanks · 6d ago
Chemomab Therapeutics, Scipher Medicine announce merger agreement
TipRanks · 6d ago
Chemomab Therapeutics, Scipher Medicine Strike All-Stock Merger Agreement; Combined Entity Expected To Operate Under Scipher Medicine Name, SCIP Ticker On Nasdaq
Benzinga · 6d ago
CHEMOMAB THERAPEUTICS AND PRECISION MEDICINE PIONEER SCIPHER MEDICINE ANNOUNCE MERGER AGREEMENT TO ADVANCE NEBOKITUG IN AN AI-POWERED PHASE 2 TRIAL IN RHEUMATOID ARTHRITIS
Reuters · 6d ago
Chemomab agrees to merge with Scipher Medicine in stock deal, combined firm to trade as SCIP
PUBT · 6d ago
Weekly Report: what happened at CMMB last week (0629-0703)?
Weekly Report · 07/06 09:07
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
NASDAQ · 07/03 05:15
11 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 07/02 17:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 07/01 21:05
Weekly Report: what happened at CMMB last week (0622-0626)?
Weekly Report · 06/29 09:07
Weekly Report: what happened at CMMB last week (0615-0619)?
Weekly Report · 06/22 09:08
Weekly Report: what happened at CMMB last week (0608-0612)?
Weekly Report · 06/15 09:08
Weekly Report: what happened at CMMB last week (0601-0605)?
Weekly Report · 06/08 09:07
Chemomab Therapeutics director Gwen A. Melincoff files initial beneficial ownership statement
PUBT · 06/03 20:19
More
Webull provides a variety of real-time CMMB stock news. You can receive the latest news about Chemomab Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CMMB
Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.